172 related articles for article (PubMed ID: 36881358)
1. Meta-analysis of the relations between gut microbiota and pathogens and Parkinson's disease.
Zhou S; Li B; Deng Y; Yi J; Mao G; Wang R; Zeng W; Liu B; Wu D; Liu F
Adv Clin Exp Med; 2023 Jun; 32(6):613-621. PubMed ID: 36881358
[TBL] [Abstract][Full Text] [Related]
2. The Association Between the Gut Microbiota and Parkinson's Disease, a Meta-Analysis.
Shen T; Yue Y; He T; Huang C; Qu B; Lv W; Lai HY
Front Aging Neurosci; 2021; 13():636545. PubMed ID: 33643026
[TBL] [Abstract][Full Text] [Related]
3. Association between increased and decreased gut microbiota abundance and Parkinson's disease: A systematic review and subgroup meta-analysis.
Bai F; You L; Lei H; Li X
Exp Gerontol; 2024 Jun; 191():112444. PubMed ID: 38679353
[TBL] [Abstract][Full Text] [Related]
4. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
Lai F; Jiang R; Xie W; Liu X; Tang Y; Xiao H; Gao J; Jia Y; Bai Q
Neurochem Res; 2018 Oct; 43(10):1986-1999. PubMed ID: 30171422
[TBL] [Abstract][Full Text] [Related]
5. Parkinson's Disease Medication Alters Small Intestinal Motility and Microbiota Composition in Healthy Rats.
van Kessel SP; Bullock A; van Dijk G; El Aidy S
mSystems; 2022 Feb; 7(1):e0119121. PubMed ID: 35076270
[TBL] [Abstract][Full Text] [Related]
6. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls.
Unger MM; Spiegel J; Dillmann KU; Grundmann D; Philippeit H; Bürmann J; Faßbender K; Schwiertz A; Schäfer KH
Parkinsonism Relat Disord; 2016 Nov; 32():66-72. PubMed ID: 27591074
[TBL] [Abstract][Full Text] [Related]
7. The Gut and Nonmotor Symptoms in Parkinson's Disease.
Klingelhoefer L; Reichmann H
Int Rev Neurobiol; 2017; 134():787-809. PubMed ID: 28805583
[TBL] [Abstract][Full Text] [Related]
8. High levels of
Zuo S; Wang H; Zhao Q; Tang J; Wang M; Zhang Y; Sang M; Tian J; Wang P
Front Integr Neurosci; 2022; 16():1054627. PubMed ID: 36686268
[TBL] [Abstract][Full Text] [Related]
9. New hope for Parkinson's disease treatment: Targeting gut microbiota.
Fan HX; Sheng S; Zhang F
CNS Neurosci Ther; 2022 Nov; 28(11):1675-1688. PubMed ID: 35822696
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori Eradication in Parkinson's Disease: A Randomized Placebo-Controlled Trial.
Tan AH; Lim SY; Mahadeva S; Loke MF; Tan JY; Ang BH; Chin KP; Mohammad Adnan AF; Ong SMC; Ibrahim AI; Zulkifli N; Lee JK; Lim WT; Teo YT; Kok YL; Ng TY; Tan AGS; Zulkifle IM; Ng CK; Ee SS; Arafin S; Mohamad Shukori K; Vadivelu JS; Marras C; Fox SH; Lang AE
Mov Disord; 2020 Dec; 35(12):2250-2260. PubMed ID: 32894625
[TBL] [Abstract][Full Text] [Related]
11. Gut Microbiota and Its Repercussion in Parkinson's Disease: A Systematic Review in Occidental Patients.
Proano AC; Viteri JA; Orozco EN; Calle MA; Costa SC; Reyes DV; German-Montenegro M; Moncayo DF; Tobar AC; Moncayo JA
Neurol Int; 2023 Jun; 15(2):750-763. PubMed ID: 37368331
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota are related to Parkinson's disease and clinical phenotype.
Scheperjans F; Aho V; Pereira PA; Koskinen K; Paulin L; Pekkonen E; Haapaniemi E; Kaakkola S; Eerola-Rautio J; Pohja M; Kinnunen E; Murros K; Auvinen P
Mov Disord; 2015 Mar; 30(3):350-8. PubMed ID: 25476529
[TBL] [Abstract][Full Text] [Related]
13. Gut brain axis: an insight into microbiota role in Parkinson's disease.
Moustafa SA; Mohamed S; Dawood A; Azar J; Elmorsy E; Rizk NAM; Salama M
Metab Brain Dis; 2021 Oct; 36(7):1545-1557. PubMed ID: 34370175
[TBL] [Abstract][Full Text] [Related]
14. Brain-gut-microbiota axis in Parkinson's disease.
Mulak A; Bonaz B
World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
[TBL] [Abstract][Full Text] [Related]
15. Effects of Gut Microbiota Alterations on Motor, Gastrointestinal, and Behavioral Phenotype in a Mouse Model of Parkinson's Disease.
Radisavljevic N; Cirstea M; Bauer K; Lo C; Metcalfe-Roach A; Bozorgmehr T; Bar-Yoseph H; Brett Finlay B
J Parkinsons Dis; 2022; 12(5):1479-1495. PubMed ID: 35599496
[TBL] [Abstract][Full Text] [Related]
16. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease.
Lin CH; Chen CC; Chiang HL; Liou JM; Chang CM; Lu TP; Chuang EY; Tai YC; Cheng C; Lin HY; Wu MS
J Neuroinflammation; 2019 Jun; 16(1):129. PubMed ID: 31248424
[TBL] [Abstract][Full Text] [Related]
17. Exploring the Connection Between the Gut Microbiome and Parkinson's Disease Symptom Progression and Pathology: Implications for Supplementary Treatment Options.
Chan DG; Ventura K; Villeneuve A; Du Bois P; Holahan MR
J Parkinsons Dis; 2022; 12(8):2339-2352. PubMed ID: 36278360
[TBL] [Abstract][Full Text] [Related]
18. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
Dodiya HB; Forsyth CB; Voigt RM; Engen PA; Patel J; Shaikh M; Green SJ; Naqib A; Roy A; Kordower JH; Pahan K; Shannon KM; Keshavarzian A
Neurobiol Dis; 2020 Feb; 135():104352. PubMed ID: 30579705
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota in patients with Parkinson's disease in southern China.
Lin A; Zheng W; He Y; Tang W; Wei X; He R; Huang W; Su Y; Huang Y; Zhou H; Xie H
Parkinsonism Relat Disord; 2018 Aug; 53():82-88. PubMed ID: 29776865
[TBL] [Abstract][Full Text] [Related]
20. Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson's disease.
Li F; Wang P; Chen Z; Sui X; Xie X; Zhang J
Neurosci Lett; 2019 Aug; 707():134297. PubMed ID: 31200089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
